Concerning breast cancer, using MCF7 breast cancer cells, Min et al. [68] in their research assessed the possible action of bioactive flavone, which could inhibit the expression of CYP19 through the use of different methods, including quantitative real-time PCR, immunoblot analysis, and reverse transcription PCR. This evidence concerns the gene CYP19A1 and breast carcinoma.